Posted on 07/16/2021 9:43:36 PM PDT by SeekAndFind
Edited on 07/17/2021 6:03:48 AM PDT by Sidebar Moderator. [history]
At one point, Johnson & Johnson (NYSE: JNJ) seemed to have a pretty good shot at becoming the leader in the COVID-19 vaccine market. Unlike rival vaccines, J&J's vaccine required only a single dose. The company even committed to selling its vaccine at cost during the pandemic, giving it a big price advantage compared to the vaccines developed by Pfizer and Moderna.
(Excerpt) Read more at nasdaq.com ...
It’s also the only vaccine the government seems to “shun” or “attack”. So if the government is against them then I’m for them....
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.